Literature DB >> 20446090

Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.

Izabela Guimarães Barbosa1, Rodrigo Barreto Huguet, Vanessa Amaral Mendonça, Lirlândia Pires Sousa, Fernando Silva Neves, Moisés Evandro Bauer, Antônio Lúcio Teixeira.   

Abstract

Bipolar disorder (BD) has been associated with a proinflammatory state in which TNF-α seems to play a relevant role. The aim of the present study was to evaluate the plasma levels of TNF-α and its soluble receptors (sTNFR1 and sTNFR2) in BD patients in mania and euthymia in comparison with control subjects. We evaluated 53 BD patients (34 in mania and 19 in euthymia) and 38 healthy subjects. All subjects were assessed by the Mini-International Neuropsychiatry Interview (MINI-Plus). Patients were also evaluated by the Young Mania Rating Scale (YMRS) and by Hamilton Depression Rating Scale (HDRS). Plasma TNF-α and its soluble receptors were measured by ELISA. The plasma TNF-α and sTNFR2 levels did not differ between groups, but higher sTNFR1 levels were found in BD patients. Of note, BD patients in mania had higher sTNFR1 levels than BD patients in euthymia and controls. The sTNFR1 and sTNFR2 levels correlated with BD duration, and sTNFR2 levels correlated with age of patients. Our data indicate a proinflammatory status in BD patients during mania and further suggest that inflammatory mechanisms may be involved with the physiopathology of BD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446090     DOI: 10.1007/s00406-010-0116-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  26 in total

Review 1.  Cytokines and the brain: implications for clinical psychiatry.

Authors:  Z Kronfol; D G Remick
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

2.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

Authors:  Yong-Ku Kim; Hyun-Gang Jung; Aye-Mu Myint; Hyun Kim; Sun-Hwa Park
Journal:  J Affect Disord       Date:  2007-04-16       Impact factor: 4.839

5.  Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Authors:  Angelo B Cunha; Ana C Andreazza; Fabiano A Gomes; Benicio N Frey; Leonardo E da Silveira; Carlos A Gonçalves; Flávio Kapczinski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

Review 6.  Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.

Authors:  Benjamin I Goldstein; David E Kemp; Joanna K Soczynska; Roger S McIntyre
Journal:  J Clin Psychiatry       Date:  2009-06-02       Impact factor: 4.384

7.  Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.

Authors:  Paula Scalzo; Arthur Kümmer; Francisco Cardoso; Antônio Lúcio Teixeira
Journal:  J Neuroimmunol       Date:  2009-09-03       Impact factor: 3.478

Review 8.  A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders.

Authors:  Norbert Müller; Markus J Schwarz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

Review 9.  TNF-alpha as a molecular target in bipolar disorder.

Authors:  Elisa Brietzke; Flávio Kapczinski
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-01-16       Impact factor: 5.067

10.  Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.

Authors:  Hubertus Himmerich; Dagmar Koethe; Andreas Schuld; Alexander Yassouridis; Thomas Pollmächer
Journal:  Psychopharmacology (Berl)       Date:  2004-11-25       Impact factor: 4.530

View more
  29 in total

1.  Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Authors:  Rukiye Çolak Sivri; Ayhan Bilgiç; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-01-04       Impact factor: 4.785

Review 2.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

3.  Differential diagnosis of major depression and bipolar disorder.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03       Impact factor: 5.270

4.  sTNFr1 and it's contributory role in the evolution and progression of different psychiatric disorders.

Authors:  S Kapoor
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

5.  Proinflammatory Cytokines, Mood, and Sleep in Interepisode Bipolar Disorder and Insomnia: A Pilot Study With Implications for Psychosocial Interventions.

Authors:  Michael R Dolsen; Adriane M Soehner; Allison G Harvey
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

6.  Effect of Increased Neutrophil-to-Lymphocyte Ratio (NLR) and Decreased Mean Platelet Volume (MPV) Values on Inflammation in Acute Mania.

Authors:  Hasan Mayda; Ahmet Ahsen; Erman Bağcioğlu; Ahmet Öztürk; Bülent Bahçeci; Etem Soyuçok; Erol Başpinar; Memnune Sena Ulu
Journal:  Noro Psikiyatr Ars       Date:  2016-12-01       Impact factor: 1.339

7.  Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder.

Authors:  Marcin Siwek; Magdalena Sowa-Kućma; Krzysztof Styczeń; Paulina Misztak; Rafał J Nowak; Bernadeta Szewczyk; Dominika Dudek; Janusz K Rybakowski; Gabriel Nowak; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-09-23       Impact factor: 5.590

Review 8.  The immunology of bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Machado-Vieira; Jair C Soares; Antonio L Teixeira
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

9.  Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Bipolar Disord       Date:  2015-08-08       Impact factor: 6.744

10.  Bipolar disorder moderates associations between linoleic acid and markers of inflammation.

Authors:  Ya-Wen Chang; Shervin Assari; Alan R Prossin; Laura Stertz; Melvin G McInnis; Simon J Evans
Journal:  J Psychiatr Res       Date:  2016-10-27       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.